Mannose-binding lectin genotypes and susceptibility to epstein-barr virus infection in infancy

Jeppe T Friborg1, Ruth F Jarrett, Anders Koch

  • 1Department of Epidemiology Research, Statens Serum Institut, 2300 Copenhagen S, Denmark.

Insights

Mannose-binding lectin (MBL) insufficiency in children under 4 in Greenland was linked to lower Epstein-Barr virus (EBV) infection rates. This suggests MBL plays a role in how infants fight off EBV.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • Mannose-binding lectin (MBL) is a key component of the innate immune system.
  • MBL plays a role in pathogen recognition and complement activation.
  • Epstein-Barr virus (EBV) is a common human herpesvirus with significant public health implications.

Purpose of the Study:

  • To investigate the association between MBL2 genotypes and EBV serological markers in young children.
  • To determine if MBL deficiency influences the susceptibility or course of primary EBV infection in infancy.

Main Methods:

  • A cohort study was conducted in Greenland involving children under 4 years of age.
  • MBL2 genotypes were determined for each child.
  • Epstein-Barr virus (EBV) antibody levels (seropositivity and time to seroconversion) were measured.

Main Results:

  • Children with MBL insufficiency exhibited significantly lower EBV seropositivity rates compared to MBL-sufficient children.
  • The time required for EBV seroconversion was notably longer in MBL-insufficient children.
  • These findings suggest a protective role for MBL against EBV in early childhood.

Conclusions:

  • MBL insufficiency is associated with altered EBV infection dynamics in young children.
  • MBL appears to be involved in the primary immune response to EBV infection during infancy.
  • Further research is warranted to elucidate the precise mechanisms of MBL's role in EBV pathogenesis.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...